Postmenopausal Osteoporosis
Showing 1 - 25 of 3,048
Postmenopausal Osteoporosis Trial in Seoul (Risedronate Sodium 35 MG [Actonel], Calcium Vitamin D combination)
Not yet recruiting
- Postmenopausal Osteoporosis
- Risedronate Sodium 35 MG [Actonel]
- Calcium Vitamin D combination
-
Seoul, Seodaemun-gu, Korea, Republic ofSeverance Hospital
Nov 29, 2022
Osteoporosis, Postmenopausal Trial in Clermont-Ferrand (Cohort follow-up)
Recruiting
- Osteoporosis, Postmenopausal
- Cohort follow-up
-
Clermont-Ferrand, FranceCHU de Clermont-Ferrand
Oct 6, 2022
Influence of Specifically Designed Exercise Program on Serum Matrix Metalloproteinases and Functional Status in Women With
Completed
- Influence of Specifically Designed Exercise Program on Serum Matrix Metalloproteinases and Functional Status in Women With Postmenopausal Osteoporosis
- exercises
-
Belgrade, SerbiaTamara Filipovic
Nov 14, 2022
Postmenopausal Osteoporosis Trial in Boston (Romosozumab, Denosumab)
Recruiting
- Postmenopausal Osteoporosis
-
Boston, MassachusettsMassachusetts General Hospital
Jul 14, 2022
Osteoporosis, Postmenopausal Trial in Port Saint Lucie (TVB-009, Prolia®)
Active, not recruiting
- Osteoporosis, Postmenopausal
- TVB-009
- Prolia®
-
Port Saint Lucie, FloridaSite 10101
Feb 1, 2023
Postmenopausal Osteoporosis Trial in Beijing (Minodronate, Alendronate)
Not yet recruiting
- Postmenopausal Osteoporosis
-
Beijing, Beijing, ChinaPeking University Third Hospital
Dec 8, 2022
Hypovitaminosis D, Osteoporosis, Postmenopausal, Menopause Trial in Mexico City (Cholecalciferol)
Completed
- Hypovitaminosis D
- +2 more
-
Mexico City, Gustavo A. Madero, MexicoPatricia Loranca-Moreno
Jan 24, 2023
Postmenopausal Osteoporosis Trial in Cairo (device, behavioral, dietary supplement)
Not yet recruiting
- Postmenopausal Osteoporosis
- Ultraviolet Radiation
- +2 more
-
Cairo, EgyptKasr Alainy medical school
Dec 6, 2022
Surveillance of EDIROL in Postmenopausal Osteoporosis
Not yet recruiting
- Postmenopausal Osteoporosis
- Eldecalcitol soft capsules
-
Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Jun 21, 2022
Osteopenia, Osteoporosis, Postmenopausal Osteoporosis Trial in Birmingham (Exercise training)
Not yet recruiting
- Osteopenia
- +3 more
- Exercise training
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Nov 16, 2022
Postmenopausal Osteoporosis Trial in Changchun (JMT103, Denosumab, Placebo)
Recruiting
- Postmenopausal Osteoporosis
- JMT103
- +2 more
-
Changchun, Jilin, ChinaThe Second Hospital of Jilin University
Jul 14, 2022
Bone Loss, Post Menopausal Osteoporosis, Mineralization Trial in Poznan (Probiotic group, Placebo group)
Enrolling by invitation
- Bone Loss
- +2 more
- Probiotic group
- Placebo group
-
Poznań, Wielkopolskie, PolandPoznan University of Life Sciences
Apr 26, 2022
Osteoporosis, Postmenopausal Trial in Clermont-Ferrand (Follow-up of patients with postmenopausal osteoporosis, with or without
Recruiting
- Osteoporosis, Postmenopausal
- Follow-up of patients with postmenopausal osteoporosis, with or without fractures, requiring initiation of injectable bisphosphonate therapy as part of their usual care
- Follow-up of patients with postmenopausal osteoporosis, fractured or not, requiring initiation of injectable bisphosphonate therapy as part of care with magnesium supplementation
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Jun 29, 2022
Postmenopausal Osteoporosis Trial in Uherské Hradište (ENZ215, Prolia)
Recruiting
- Postmenopausal Osteoporosis
- ENZ215
- Prolia
-
Uherské Hradiště, CzechiaMEDICAL PLUS s.r.o.
Jul 30, 2022
Osteoporosis, Postmenopausal Trial in Yantai (Denosumab)
Recruiting
- Osteoporosis, Postmenopausal
- Denosumab
-
Yantai, Shandong, ChinaShandong Boan Biotechnology Co., Ltd.
May 2, 2023
Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal Trial (Denosumab, Alendronate Sodium)
Not yet recruiting
- Nonalcoholic Fatty Liver
- Osteoporosis, Postmenopausal
- Denosumab
- Alendronate Sodium
- (no location specified)
Aug 6, 2022
Cross -Cultural Validation of ECOS-16 Questionnaire in Urdu
Completed
- Postmenopausal Osteopenia
- +4 more
-
Lahore, Punjab, PakistanSaima Riaz
Jun 15, 2022
Postmenopausal Osteoporosis, Postmenopause, Hyperparathyroidism, Secondary Trial in Mexico City (Cholecalciferol)
Completed
- Postmenopausal Osteoporosis
- +4 more
-
Mexico City, MexicoPeri-postmenopause and bone metabolism clinic. Regional Hospital
Apr 30, 2022
Postmenopausal Osteoporosis Trial in Boston (Teriparatide, Denosumab)
Completed
- Postmenopausal Osteoporosis
-
Boston, MassachusettsMassachusetts General Hospital
Jul 28, 2022
Osteoporosis Trial in Changsha (SHR-1222, Placebo)
Active, not recruiting
- Osteoporosis
- SHR-1222
- Placebo
-
Changsha, Hunan, China2nd Xiangya Hospital , Chinese Academy of Medical Sciences
Jan 5, 2022
Low Bone Mineral Density, Postmenopausal Osteoporosis Trial in China (Eldecalcitol capsules, Calcitriol capsules)
Not yet recruiting
- Low Bone Mineral Density
- Postmenopausal Osteoporosis
- Eldecalcitol capsules
- Calcitriol capsules
-
Changsha, China
- +20 more
Jun 5, 2023
Low Bone Mineral Density, Postmenopausal Osteoporosis Trial (Placebo to Romosozumab, Alendronate, Teriparatide)
Completed
- Low Bone Mineral Density
- Postmenopausal Osteoporosis
- Placebo to Romosozumab
- +6 more
- (no location specified)
Sep 9, 2022
Osteoporosis in Postmenopausal Women Trial (Eldecalcitol, Native Vitamin D, Denosumab)
Not yet recruiting
- Osteoporosis in Postmenopausal Women
- Eldecalcitol
- +3 more
- (no location specified)
Jun 1, 2023